| Financial Year |
March 31 2023 |
| Monetary Funds |
205,198,355.58 |
| Held-for-trading Financial Assets |
921,142,866.75 |
| Notes Receivable |
10,226,885.44 |
| Accounts Receivable |
69,233,165.65 |
| Advances to Suppliers |
4,664,704.18 |
| Other Receivables |
4,330,269.18 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
97,456,343.78 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
16,860,035.25 |
| Total Current Assets |
1,329,112,625.81 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
819,539,195.58 |
| Investment Properties |
-- |
| Fixed Assetes |
548,583,230.94 |
| Under-construction Projects |
557,538.28 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
52,723,389.90 |
| R&D expenses |
186,415,058.19 |
| Goodwill |
21,865,087.82 |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
4,567,046.82 |
| Other Non-Current Assets |
10,994,720.00 |
| Sub-Total of Non-Current Assets |
2,219,519,939.96 |
| Total Assets |
3,548,632,565.77 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
21,349,933.00 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
5,756,201.57 |
| Taxes Payable |
3,398,240.17 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
15,365,411.05 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
1,112,373.22 |
| Sub-Total of Current Liabilities |
55,538,876.08 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
81,164,316.41 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
81,164,316.41 |
| Total Liabilities |
136,703,192.49 |
| Paid-In Capital(Or Share Stock) |
481,666,400.00 |
| Capital Surplus |
845,927,046.31 |
| Surplus Reserve |
244,683,544.13 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,802,122,263.92 |
| Minority Stockholder's Interest |
37,669,274.78 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,374,260,098.50 |
| Owner's Equity（Stockholder's Equity） |
3,411,929,373.28 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,548,632,565.77 |
